<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/Vitamin_B3.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:34:07 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="2926008">
<meta name="Category" content="Supp">
<meta name="Article" content="Vitamin_B3">
<title>Vitamina B3-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Vitamina B3</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Vitamin_B3.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">McKenney JM, Proctor JD, Harris S, Chinchili VM. A comparison of the efficacy
and toxic effects of sustained&#8212;vs immediate-release niacin in hypercholesterolemic
patients. <em>JAMA</em> 1994;271:672&#8211;7.</li>

<li class="Ref">Knopp RH, Ginsberg J, Albers JJ, et al. Contrasting effects of unmodified and
time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of
action of niacin. <em>Metabolism</em> 1985;34:642&#8211;50.</li>

<li class="Ref">Gray DR, Morgan T, Chretien SD, Kashyap ML. Efficacy and safety of
controlled-release niacin in dyslipoproteinemic veterans. <em>Ann Intern Med</em>
1994;121:252&#8211;8.</li>

<li class="Ref">Rader JI, Calvert RJ, Hathcock JN. Hepatic toxicity of unmodified and
time-release preparations of niacin. <em>Am J Med</em> 1992;92:77&#8211;81 [Review].</li>

<li class="Ref">Knopp RH. Niacin and hepatic failure. <em>Ann Intern Med</em> 1989;111:769
[letter].</li>

<li class="Ref">Goldberg A, Alagona P Jr, Capuzzi DM, et al. Multiple-dose efficacy and safety
of an extended-release form of niacin in the management of hyperlipidemia. <em>Am J
Cardiol</em> 2000;85:1100&#8211;5.</li>

<li class="Ref">Garg R, Malinow M, Pettinger M, Upson B, Hunninghake D. Niacin treatment
increases plasma homocyst(e)ine levels. <em>Am Heart J</em> 1999;138:1082&#8211;7.</li>

<li class="Ref">Brown WV. Niacin for lipid disorders. <em>Postgrad Med</em>
1995;98:185&#8211;93 [review].</li>

<li class="Ref">Guyton JR. Effect of niacin on atherosclerotic cardiovascular disease. <em>Am
J Cardiol</em> 1998;82(12A):18U&#8211;23U [review].</li>

<li class="Ref">Welsh AL, Ede M. Inositol hexanicotinate for improved nicotinic acid therapy.
<em>Int Record Med</em> 1961;174:9&#8211;15.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Supp/Vitamin_B3.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:34:07 GMT -->
</html>

